MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies Read More » October 28, 2025
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes Read More » October 2, 2025
WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8 million Read More » October 1, 2025
